Turku University Hospital, Department of Child Psychiatry, P.O. Box 52, 20521 Turku, Finland.
Psychiatry Res. 2013 May 30;212(2):164-5. doi: 10.1016/j.pscychresns.2013.02.001. Epub 2013 Apr 6.
The serotonin transporter (SERT) in attention-deficit hyperactivity disorder (ADHD) patients has not been explored by earlier positron emission tomography (PET) studies. We measured SERT availability in female ADHD patients (n=8) and healthy controls (n=14) with PET and [11C]MADAM as a tracer. No significant group differences in [11C]MADAM binding potential were noted.
先前的正电子发射断层扫描 (PET) 研究并未探讨注意力缺陷多动障碍 (ADHD) 患者的血清素转运蛋白 (SERT)。我们使用 PET 和 [11C]MADAM 作为示踪剂测量了女性 ADHD 患者(n=8)和健康对照组(n=14)的 SERT 可及性。未观察到 [11C]MADAM 结合潜能在组间存在显著差异。